Abstract Body

Background:

Drug toxicity in people living with HIV (PLHIV) using cART is a concern. Nucleoside analogues are associated with mitochondrial damage. Two-drug regimens (2DR), such as DTG (integrase strand inhibitor) and 3TC may reduce drug toxicity, but the molecular effects remain unclear. Systemic effects of DTG/3TC and triple therapies (3DR) were studied using multi-omics.

Methods:

Data are used from the 2000HIV (NTC03994835) study that includes discovery (n=1275) and validation (n=212) cohorts of PLHIV with ~11.5 years of cART stratified by treatment regimen. We measured ~2368 plasma proteins (Olink Explore), and ~58347 genes expression by PBMC Bulk RNA-seq. We compared differential gene (DEG) and protein (DEP) expression and enriched pathways between PLHIV using DTG/3TC (n=188) versus 3DR containing INSTI (3DR-INSTI, n=526) or without (3DR-non-INSTI, n=773), and compared 3DR-INSTI versus 3DR-non-INSTI, adjusting for sex, age, ethnicity, and pre-cART conditions.

Results:

Discovery cohort data showed limited DEG (5 up, 15 down) and DEP (2 up, 27 down) in DTG/3TC compared to 3DR-INSTI (Figure). DTG/3TC and 3DR-non-INSTI comparison showed 21 DEG (14 down) and 131 DEP (119 down). 3DR-INSTI versus 3DR-non-INSTI revealed no DEG and limited DEP (63 up, 83 down). Gene set enrichment analysis on the total summary statistics of genes and proteins ranked by -log10(p-value)*sign(log2FC) revealed significant results (p<0.05). DTG/3TC genes compared to 3DR-INSTI revealed the up-regulation of the ATPase complex and down-regulation of the Oxidative stress pathway; meanwhile proteins revealed a down-regulation of the Biological oxidations with ALDH1A1, ACY1, ACY3, and ADH4 DEPs as leading markers. DTG/3TC compared to 3DR-non-INSTI genes showed an up-regulation of the TCA cycle with PC DEG as leading marker and down-regulation of the OXPHOS system with TMEM70 DEG as leading marker of the latest, while proteins revealed a down-regulation of the Biological oxidation enzymes and Oxidoreductase activity with ADH4, AKR7L, DCXR, and ADH1B DEPs leading markers. 3DR-INSTI proteins compared 3DR-non-INSTI showed a down-regulation of the Fat digestion and Metabolism with CKMT1A, RBP2, FABP2, and DDC DEPs as leading markers. The direction of our findings was confirmed in the validation cohort.

Conclusions:

This study suggests that DTG/3TC reduces mitochondrial and oxidative stress in PLHIV compared to 3DR containing NRTIs. We also showed the negative effects on fat metabolism of INSTI compared to non-INSTI based regimens.